Urinary metabolites of aromatic amino acids in schizophrenia

Urinary metabolites of aromatic amino acids in schizophrenia

Life Sciences No . 2, pp . 61-64, 1962 " Britain . Pergamon Press Ltd . Printed in Great URINARY METABOLITES OF AROMATIC AMINO ACIDS IN SCHIZOPHREN...

174KB Sizes 3 Downloads 79 Views

Life Sciences No . 2, pp . 61-64, 1962 " Britain .

Pergamon Press Ltd .

Printed in Great

URINARY METABOLITES OF AROMATIC AMINO ACIDS IN SCHIZOPHRENIA Michael H . Briggs and Natalie Harvey Victoria University of Wellington, New Zealand (Received g January 1962j Tf~RS have been a nimber ~ reports that the urine of schisophx~enics contains unusual aromatio com~peunda not Pound in normal urine, nor in that from other psychotica . i-5 Moreover, one group ad waa~kers~ have offered evidence that these unusual metabolites are derived from dietary pher~rlalanine and tyrosine and can be eliminated from schizophrenics " urine by feeding a diet low in these two amino acids.

This evidence can be ezplaiaed if there is an

impairnient in schizophrenics of the phenTplalanine aQidase system .

In

other work6 ' 7 evidence has been pa~esented for an excessive breakdam of ascorbic acid in schizophrenics .

Nos ascorbic acid is an activator of orge

enzyme of the phenylalanine oxidase system, ~-hydro~pher~ylpyruvate aad.daae .8 Consequently, the obsertrations of the pa"evious worlrors could be ezplained by a partial inhibition of this enzyme in the tissues aâ schizophrenics . To examine this hypothesis we have compared the ara®atic metabolites gresent in schizophrenics' urine with those in urine from a na~rmal group and from a group of non-schizophrenic psychotics .

We have looked particularly

for the pa"esenee and absence of the taro compounds knosn to be excreted. during the inhibition of ~-hydroxypher~ylpyruvate ox;.dase :

~hydroxyphenylpyzuvats

and ~-hydrozyphenyllactate . 8 Clinical details of the patients investigated are given in Table 1 . Diagnosis of schizophrenia was based on clinical evidence of hallucinations ; grandiose, persecution and other delusions ; excitement .

withdrawal and periodic

Both groups of patients included highly active, inactive and

subjects oaf variable activity.

All groups received a normal mixed diet 61

URINA;tY METABOLITES

6Z which included fresh fruits .

iJ~, .

PIo estimate of the amounts of ascorbate and

aromatic amino acids in the diets was made, but both groups of patients received identical foods and the non-schizophrenics thus form a control group for the schizophrenics for these factors .

Measurements of total

urinary excretion of ascorbate and its major metabolites (dehy~7roascorbate and diketogulonate) gave similar results for each group.

This provides adr3itional

evidence for e similar, and adequate, dietary supply of the vitamin for all subjects . TARIE 1 Clinical Details of Patients and Subjects

Group

No .

Schizophrenic Patients

15

:~on-schizophrenic Patients

12

Normal Subjects

Diagnosis 10 paranoid 5 simple

Age (yrs .) Range Mean x-52

6 depuressives 1 senile mania state 1 paraphrenic 3x72 2 manic depressive 1 psychopathic pe rs onality 1 alcoholic

18

20-58

-

Duration of Tllness (yra . Range Mean

ßody Wt . (lbs .) Range Mean

1,0

2-35

12

121+-196 162

~

1-35

7

1 26-178 156

38

-

135-185

165

TJrine fran 15 male schizophrenics, 12 male non-schizophrenic psychotics, and 18 normal males was submitted to paper chromatography .

experiments have

been conducted with untreated urine s, concentrated urines, and. with ether extracted urines .

Solvents used were chloroform-acetic acid-water and 20;

potassium chloride solution .

Compounds were detected by first examining the

chromato rams wider an ultra-violet lamp, then by spraying freshly diazotized sulphanilic acid, followed by sodium carbonate solution . Results are summarized in Table 2. 3ooth et a1 . 9

~, values are those established by

No .2

63

URINARY METABOLITES TABLE 2 Aromatic Amino Acid metabolites in Urine

Rf Metabolite

1

No . of subjects in which detected

2

Normal subjects (18)

Schizophrenic patients

(15)

Non-schizophrenic patients (12)

0,13

0,90

5

15

4

~hydroxypher~yllactate

0 .11

0 .76

3

12

4

~hydro~rphe~lacetate

0,1,1 .

0,78

13

14

12

p-hydroxypheruylpyruvate

solvent 1 - chloroform-acetic acid-water solvent 2 - ~ KC1 solution

These results clearly indicate an abnormality in the metabolism of tyrosine in schizophrenics .

Other aromtic compounds that have not yet been identified

also were poresent only in schizophrenics' urine. The most likely explanation of the metabolic abnormality in schizop~hrenica is a partial inhibition of ~-hydraarypheruylpyruvate axidase due to sub-optimum amounts A of ascorbate. 7

blockage oP the phetiplalanine oxidase system at a

different level occurs in another mental disorder, phcnylpyruvic oligophrenia . l0 The mental defect in both cases could be caused by a toxic effect of the circulatir~ aromatic metabolites, or by an imbalance in aromatic transformations, Thus an increased synthesis of epinephrine from dihydroxypheu>,glelanine would be a likely result a~f impaired oxidation of tyrosine .

There is knave to be

increased tissue epinephrine in scurvy, ll and there is experimental evidence a~P l2-13 Excessepinephrine abnormal epinephrine metabolism in schizophrenics . cail.d be metabolised to assns compound having psychotomimetic properties, such as adrenochrame, adrenolutin, ar other metabolite bearing a structural resemblance to riescaline our related hallucinogen .

Acknowled.Rement - We are grateful for the assistance of Dr . B.D . Hart and his staff the Porirua Hospital .

64

URINARY METABOLITES References

1.

b~ . K. YOUNG, JR ., Univ . Texas Pibl . No . 5109, 189 (1951) .

2.

I. SANO, Folie Psychiat . Neurol . Japan =$, 218 (1954) "

3.

P. L. Mcf~R, B . G . kcGEEit aryl gf. C . GIHSON, Science ~, 1029 (1956 )

1{..

P. L. MoGEER, $ . G. Md~R and Yl . C . GIRSON, Sc ience ~, 1078 (1956 ) .

5.

P. L. McK~ER, F . S . McNAIR, E . G . NrcC~R anä. 1P . C . GIBSCMI, J. t?erv. Ment . Dis. ~, 1 and 11

(1957) "

6.

G . B. KITTO, E . D . AI~RBRS and I~ . H . BRIGGS, to be published (1962) .

7.

M. H. ~tIGGS, N.Z . Med. J . in press (1962) .

8.

B . N . La DUE and V. G . ZAN1~'ONl, Ann . N.Y . Aced . Sci . ~2, 175 (1961) "

9.

A. N. HOO~i, l~. S . I~ASRI, D . J. ROBBINS, 0 . A. Sb~RSON, F. T . JODS and F. De SDS, J . Bio1 . Chem . 2~, 2649 (1960) .

10 .

C . MI1'~f.A, R . M . AUID and H . UDENFRIEI~, Pros . Soc. Exptl. 3io1 . bled.

.24, 634 (1957) . 11 .

A. GIE20~ and M. MARTIT~T, Bu1L Sac . Chien. Biol . ~, 456 (1941 ) .

12 .

J . R . S~THIES, Lancet ü, 308 (1958) "

13 .

1, 108 H. SUIKO9VITCH and M . D. ALTSCf?UIE, A .M .A . Arch . Gen. F~ychiat . 3

No .z